Sheen Mao-ting, director of BNHI ’ s Medical Review and Pharmaceutical Benefits Division, says cancer treatment is rife with out-of-pocket expenses, especially when you get into the realm of tailor-made targeted drugs.
經常讓病患和家屬陷入天人交戰。健保局醫審及藥材組組長沈茂庭指出，目前癌症自費用藥的情況非常多，特別是所謂量身訂製的標靶型藥物。